Last 12 months
Inside the activity.
0 purchase rows · 32 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 11 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2019 Filed Jun 12, 2019 23:44 UTC |
MORSE ANDREW RDirector
|
GrantCommon Stock | 5,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036548 · doc4.xml · nonDerivative · entry 1 MORSE ANDREW R · CIK 0001254946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,815 Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 00:30 UTC Amendment |
Regan Robert ChristopherDirector
|
GrantStock Options (right to buy) · Derivative | 7,929 | $0.00 Strike: $13.83 | $0.00 |
DisclosureSEC source: 0001209191-19-036568 · doc4a.xml · derivative · entry 5 Regan Robert Christopher · CIK 0001338856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,929 Underlying: Common Stock · 7,929 shares Expires 2029-06-11 Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 00:30 UTC Amendment |
Regan Robert ChristopherDirector
|
GrantCommon Stock | 6,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036568 · doc4a.xml · nonDerivative · entry 1 Regan Robert Christopher · CIK 0001338856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,778 Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 23:51 UTC |
Regan Robert ChristopherDirector
|
GrantStock Options (right to buy) · Derivative | 7,929 | $0.00 Strike: $13.83 | $0.00 |
DisclosureSEC source: 0001209191-19-036552 · doc4.xml · derivative · entry 5 Regan Robert Christopher · CIK 0001338856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,929 Underlying: Common Stock · 7,929 shares Expires 2029-06-11 Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 23:51 UTC |
Regan Robert ChristopherDirector
|
GrantCommon Stock | 6,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036552 · doc4.xml · nonDerivative · entry 1 Regan Robert Christopher · CIK 0001338856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,778 Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 23:48 UTC |
Persily JulieDirector
|
GrantStock Options (right to buy) · Derivative | 7,929 | $0.00 Strike: $13.83 | $0.00 |
DisclosureSEC source: 0001209191-19-036550 · doc4.xml · derivative · entry 2 Persily Julie · CIK 0001593007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,929 Underlying: Common Stock · 7,929 shares Expires 2029-06-11 Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 23:48 UTC |
Persily JulieDirector
|
GrantCommon Stock | 4,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036550 · doc4.xml · nonDerivative · entry 1 Persily Julie · CIK 0001593007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,154 Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 23:41 UTC |
Miguel Bejos AlfredoDirector
|
GrantStock Options (right to buy) · Derivative | 7,929 | $0.00 Strike: $13.83 | $0.00 |
DisclosureSEC source: 0001209191-19-036546 · doc4.xml · derivative · entry 3 Miguel Bejos Alfredo · CIK 0001777507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,929 Underlying: Common Stock · 7,929 shares Expires 2029-06-11 Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 23:41 UTC |
Miguel Bejos AlfredoDirector
|
GrantCommon Stock | 3,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036546 · doc4.xml · nonDerivative · entry 1 Miguel Bejos Alfredo · CIK 0001777507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,280 Read SEC document |
| June 11, 2019 Filed Aug 31, 2020 20:53 UTC Amendment |
Miguel Bejos AlfredoDirector
|
SaleCommon Stock | 5,724 | $13.92 | $79,678.08 |
DisclosureSEC source: 0001209191-20-048793 · doc4a.xml · nonDerivative · entry 1 Miguel Bejos Alfredo · CIK 0001777507 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Proyectos Globales de Energia y Servicios CME, S.A. de C.V. Disclosed balance after: 980,437 F1 · shares: The Reporting Person's original Form 4 omitted the sale of 5,724 shares on 6/11/19 by Projectos Globales de Energia y Servicios CME, S.A. de C.V. ("CME"). The correction of this omission results in indirect beneficial ownership of 980,437 shares as of 6/11/19. This omission was also reflected in the reported indirect beneficial ownership of shares set forth in each Form 4 filed by the Reporting Person after the original Form 4 was filed. As of 8/31/20, the Reporting Person has indirect beneficial ownership of 744,693 shares through CME. F2 · ownership.nature: The Reporting Person is the President, Chief Executive Officer and a shareholder of CME. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest in the securities. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 21:01 UTC |
Rossmiller Gregory ScottSVP & CAO
|
GrantPerformance Restricted Stock Units · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025261 · doc4.xml · derivative · entry 3 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires not disclosed F3 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F4 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. F4 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 21:01 UTC |
Rossmiller Gregory ScottSVP & CAO
|
GrantStock Options (right to buy) · Derivative | 3,750 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001209191-19-025261 · doc4.xml · derivative · entry 2 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2029-04-16 F2 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 21:01 UTC |
Rossmiller Gregory ScottSVP & CAO
|
GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025261 · doc4.xml · nonDerivative · entry 1 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,629 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 21:02 UTC |
Weller AnthonySVP/Managing Dir-Int'l Div
|
GrantPerformance Restricted Stock Units · Derivative | 6,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025262 · doc4.xml · derivative · entry 3 Weller Anthony · CIK 0001705744 · SVP/Managing Dir-Int'l Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,800 Underlying: Common Stock · 6,800 shares Expires not disclosed F3 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F4 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. F4 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 21:02 UTC |
Weller AnthonySVP/Managing Dir-Int'l Div
|
GrantStock Options (right to buy) · Derivative | 1,875 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001209191-19-025262 · doc4.xml · derivative · entry 2 Weller Anthony · CIK 0001705744 · SVP/Managing Dir-Int'l Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 1,875 shares Expires 2029-04-16 F2 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 21:02 UTC |
Weller AnthonySVP/Managing Dir-Int'l Div
|
GrantCommon Stock | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025262 · doc4.xml · nonDerivative · entry 1 Weller Anthony · CIK 0001705744 · SVP/Managing Dir-Int'l Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,110 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 21:00 UTC |
Llorca JesusEVP & CFO
|
GrantPerformance Restricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025260 · doc4.xml · derivative · entry 3 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F3 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F4 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. F4 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 21:00 UTC |
Llorca JesusEVP & CFO
|
GrantStock Options (right to buy) · Derivative | 6,250 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001209191-19-025260 · doc4.xml · derivative · entry 2 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2029-04-16 F2 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 21:00 UTC |
Llorca JesusEVP & CFO
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025260 · doc4.xml · nonDerivative · entry 1 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,249 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:59 UTC |
Gellert John MDirector · President and CEO
|
GrantPerformance Restricted Stock Units · Derivative | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025258 · doc4.xml · derivative · entry 7 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires not disclosed F7 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F8 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. F8 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:59 UTC |
Gellert John MDirector · President and CEO
|
GrantStock Options (right to buy) · Derivative | 8,750 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001209191-19-025258 · doc4.xml · derivative · entry 6 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 Underlying: Common Stock · 8,750 shares Expires 2029-04-16 F6 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:59 UTC |
Gellert John MDirector · President and CEO
|
GrantCommon Stock | 42,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025258 · doc4.xml · nonDerivative · entry 1 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,085 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:58 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
GrantPerformance Restricted Stock Units · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025257 · doc4.xml · derivative · entry 3 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires not disclosed F3 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F4 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. F4 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:58 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
GrantStock Options (right to buy) · Derivative | 3,750 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001209191-19-025257 · doc4.xml · derivative · entry 2 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2029-04-16 F2 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:58 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025257 · doc4.xml · nonDerivative · entry 1 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,813 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:57 UTC |
Clemons RobertEVP & COO
|
GrantPerformance Restricted Stock Units · Derivative | 18,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025256 · doc4.xml · derivative · entry 3 Clemons Robert · CIK 0001705909 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,800 Underlying: Common Stock · 18,800 shares Expires not disclosed F3 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F4 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. F4 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:57 UTC |
Clemons RobertEVP & COO
|
GrantStock Options (right to buy) · Derivative | 6,250 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001209191-19-025256 · doc4.xml · derivative · entry 2 Clemons Robert · CIK 0001705909 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2029-04-16 F2 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:57 UTC |
Clemons RobertEVP & COO
|
GrantCommon Stock | 28,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025256 · doc4.xml · nonDerivative · entry 1 Clemons Robert · CIK 0001705909 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,896 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022. Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 00:57 UTC |
Rossmiller Gregory ScottSVP & CAO
|
Tax withholdingCommon Stock | 371 | $12.09 | $4,485.39 |
DisclosureSEC source: 0001209191-19-018654 · doc4.xml · nonDerivative · entry 1 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,629 Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 00:56 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
Tax withholdingCommon Stock | 1,687 | $12.09 | $20,395.83 |
DisclosureSEC source: 0001209191-19-018652 · doc4.xml · nonDerivative · entry 1 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,813 Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 00:56 UTC |
Gellert John MDirector · President and CEO
|
Tax withholdingCommon Stock | 3,419 | $12.09 | $41,335.71 |
DisclosureSEC source: 0001209191-19-018653 · doc4.xml · nonDerivative · entry 1 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,085 Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 00:55 UTC |
Clemons RobertEVP & COO
|
Tax withholdingCommon Stock | 1,802 | $12.09 | $21,786.18 |
DisclosureSEC source: 0001209191-19-018651 · doc4.xml · nonDerivative · entry 1 Clemons Robert · CIK 0001705909 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,696 Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 00:51 UTC |
Gellert John MDirector · President and CEO
|
Tax withholdingCommon Stock | 3,345 | $14.01 | $46,863.45 |
DisclosureSEC source: 0001209191-19-017112 · doc4.xml · nonDerivative · entry 2 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,504 Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 00:49 UTC |
Clemons RobertEVP & COO
|
Tax withholdingCommon Stock | 833 | $14.01 | $11,670.33 |
DisclosureSEC source: 0001209191-19-017109 · doc4.xml · nonDerivative · entry 1 Clemons Robert · CIK 0001705909 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,498 Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 00:48 UTC |
Llorca JesusEVP & CFO
|
Tax withholdingCommon Stock | 2,789 | $14.01 | $39,073.89 |
DisclosureSEC source: 0001209191-19-017108 · doc4.xml · nonDerivative · entry 1 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,836 Read SEC document |
| March 04, 2019 Filed Mar 15, 2019 22:07 UTC Amendment |
Llorca JesusEVP & CFO
|
Tax withholdingCommon Stock | 3,376 | $14.01 | $47,297.76 |
DisclosureSEC source: 0001209191-19-019798 · doc4a.xml · nonDerivative · entry 1 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,249 Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 00:51 UTC |
Gellert John MDirector · President and CEO
|
OtherCommon Stock | 841 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017112 · doc4.xml · nonDerivative · entry 1 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · JMG Assets LLC Disclosed balance after: 45,871 F1 · kind: Distribution from Pigeon Forge Investors ("PFI"), of which the Reporting Person is a partner. Such distribution represents the Reporting Person's pecuniary interest in a distribution from de Got Capital Partners, LP ("dCP") to PFI, which is a limited partner of dCP, as part of the winding up of the business of dCP. F2 · ownership.nature: The shares reported here are indirectly owned by the Reporting Person through JMG Assets LLC. The Reporting Person is the Manager of JMG Assets LLC. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 21:21 UTC |
Weller AnthonySr VP and Managing Dir.
|
GrantStock Options (right to buy) · Derivative | 1,875 | $0.00 Strike: $11.76 | $0.00 |
DisclosureSEC source: 0001437749-19-000081 · rdgdoc.xml · derivative · entry 1 Weller Anthony · CIK 0001705744 · Sr VP and Managing Dir. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 1,875 shares Expires 2028-04-24 F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 21:21 UTC |
Gellert John MDirector · President and CEO
|
GrantStock Options (right to buy) · Derivative | 10,000 | $0.00 Strike: $11.76 | $0.00 |
DisclosureSEC source: 0001437749-19-000083 · rdgdoc.xml · derivative · entry 1 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-04-24 F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 21:21 UTC |
Llorca JesusExecutive Vice President
|
GrantStock Options (right to buy) · Derivative | 6,250 | $0.00 Strike: $11.76 | $0.00 |
DisclosureSEC source: 0001437749-19-000082 · rdgdoc.xml · derivative · entry 1 Llorca Jesus · CIK 0001705427 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2028-04-24 F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 21:20 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
GrantStock Options (right to buy) · Derivative | 2,500 | $0.00 Strike: $11.76 | $0.00 |
DisclosureSEC source: 0001437749-19-000080 · rdgdoc.xml · derivative · entry 1 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2028-04-24 F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 21:20 UTC |
Clemons RobertExecutive VP and COO
|
GrantStock Options (right to buy) · Derivative | 6,250 | $0.00 Strike: $11.76 | $0.00 |
DisclosureSEC source: 0001437749-19-000079 · rdgdoc.xml · derivative · entry 1 Clemons Robert · CIK 0001705909 · Executive VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2028-04-24 F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022. Read SEC document |
| December 21, 2018 Filed Dec 21, 2018 22:49 UTC |
Gellert John MDirector · President and CEO
|
PurchaseCommon Stock | 23,000 | $12.10 | $278,329.90 |
DisclosureSEC source: 0001437749-18-022545 · rdgdoc.xml · nonDerivative · entry 1 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · JMG Assets LLC Disclosed balance after: 45,030 F1 · price: The price reported in Column 4 is a weighted average price. The Common shares were purchased in separate transactions on the same day at prices ranging from $11.645 to $12.28 per share. The Reporting Person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares reported here are indirectly owned by the Reporting Person through JMG Assets, LLC. The Reporting Person is the Manager of JMG Assets, LLC. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 17:25 UTC |
FABRIKANT CHARLESDirector
|
SaleCommon Stock | 20,000 | $19.25 | $385,026.00 |
DisclosureSEC source: 0001690334-18-000090 · wf-form4_154327110985572.xml · nonDerivative · entry 1 FABRIKANT CHARLES · CIK 0000942692 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462,659 F1 · price: The price reported in Column 4 is a weighted average price. The Common Shares were sold in separate transactions on the same day at prices ranging from $19.10 to $19.455 per share. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2018 Filed Feb 14, 2019 16:15 UTC |
FABRIKANT CHARLESDirector
|
GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-010126 · doc5.xml · nonDerivative · entry 4 FABRIKANT CHARLES · CIK 0000942692 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · VSS Holding Corp. Disclosed balance after: 65,459 F1 · ownership.nature: Reporting Person is the President and sole stockholder. Read SEC document |
| November 15, 2018 Filed Nov 15, 2018 22:01 UTC |
Weller AnthonySr VP and Managing Dir.
|
PurchaseCommon Stock | 500 | $18.00 | $9,000.00 |
DisclosureSEC source: 0001690334-18-000088 · wf-form4_154231924549148.xml · nonDerivative · entry 1 Weller Anthony · CIK 0001705744 · Sr VP and Managing Dir. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,910 Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 21:04 UTC |
Llorca JesusExecutive Vice President
|
GrantStock Options (right to buy) · Derivative | 6,250 | $0.00 Strike: $22.38 | $0.00 |
DisclosureSEC source: 0001690334-18-000086 · wf-form4_153851427715191.xml · derivative · entry 1 Llorca Jesus · CIK 0001705427 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2028-04-24 F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 21:04 UTC |
Gellert John MDirector · President and CEO
|
GrantStock Options (right to buy) · Derivative | 10,000 | $0.00 Strike: $22.38 | $0.00 |
DisclosureSEC source: 0001690334-18-000085 · wf-form4_153851424714822.xml · derivative · entry 1 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-04-24 F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 21:03 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
GrantStock Options (right to buy) · Derivative | 2,500 | $0.00 Strike: $22.38 | $0.00 |
DisclosureSEC source: 0001690334-18-000084 · wf-form4_153851421856063.xml · derivative · entry 1 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2028-04-24 F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 21:03 UTC |
Clemons RobertExecutive VP and COO
|
GrantStock Options (right to buy) · Derivative | 6,250 | $0.00 Strike: $22.38 | $0.00 |
DisclosureSEC source: 0001690334-18-000083 · wf-form4_153851419369113.xml · derivative · entry 1 Clemons Robert · CIK 0001705909 · Executive VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2028-04-24 F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.